Halozyme Therapeutics
HALO
Hutchmed (China)
HCM
Lantheus
LNTH
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Teradata Corp
TDC
US Stock MarketDetailed Quotes
VIRX Viracta Therapeutics
- 0.213
- -0.010-4.62%
Close Jan 6 16:00 ET
- 0.216
- +0.003+1.36%
Post 20:01 ET
8.45MMarket Cap-0.19P/E (TTM)
0.239High0.187Low2.97MVolume0.205Open0.223Pre Close617.48KTurnover10.36%Turnover RatioLossP/E (Static)39.74MShares1.31052wk High-1.28P/B6.10MFloat Cap0.13252wk Low--Dividend TTM28.69MShs Float9324.000Historical High--Div YieldTTM23.45%Amplitude0.132Historical Low0.207Avg Price1Lot Size
Viracta Therapeutics News
Viracta Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Viracta Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Viracta Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Viracta Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Viracta Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Viracta Therapeutics | EFFECT: Others
Viracta Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Viracta Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Viracta Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Viracta Therapeutics | EFFECT: Others
Viracta Therapeutics | 424B3: Prospectus
Viracta Therapeutics | S-4/A: Registration of securities issued in business combination transactions (Amendment)
Viracta Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Viracta Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Viracta Therapeutics | S-4: Registration of securities issued in business combination transactions
Viracta Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Viracta Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Viracta Therapeutics | 424B5: Prospectus
Viracta Therapeutics | 424B5: Prospectus
Viracta Therapeutics | 424B5: Prospectus
